{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-10T12:51:10.358730+00:00",
  "news": [
    {
      "title": "Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNY0l3WmRKcWxmT3F4amI1LWdKOGlJZkI1T1NWYXRlNGtOTERBaUlYWlpZZHZLVzd0ZXVScTF1a21odXhVTVdlUG5ldWVxeG94VnkyRTFBSG1Ra1FQYWhkV2htc09GaHR3Tm1xbXF1YjFYSi1LQlJ3NXRTZmJnczFIeWY5NmwzU1JaT2RHeFdPYWd3c1JtNFVWcEZlNFViNGZWUml6V2YxX2ZnZktXeTF1VGtVQTlOaHVfVlY2N2JRTF83bzBYbXdPZ2lpWURJQlZuYkdhNw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNY0l3WmRKcWxmT3F4amI1LWdKOGlJZkI1T1NWYXRlNGtOTERBaUlYWlpZZHZLVzd0ZXVScTF1a21odXhVTVdlUG5ldWVxeG94VnkyRTFBSG1Ra1FQYWhkV2htc09GaHR3Tm1xbXF1YjFYSi1LQlJ3NXRTZmJnczFIeWY5NmwzU1JaT2RHeFdPYWd3c1JtNFVWcEZlNFViNGZWUml6V2YxX2ZnZktXeTF1VGtVQTlOaHVfVlY2N2JRTF83bzBYbXdPZ2lpWURJQlZuYkdhNw?oc=5\" target=\"_blank\">Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-02-10T12:27:54+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call - Finviz",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOYy04N1ZKcGR4NTFZYmg0cDZYbGNnQ0FEbmxnZmQ3MzRBeGZ4R0Q1a2wyaENNakhXZ29hRFpEb2FvVWFLUlZ6QnlIVFNYN2hOaFFsSkZCLWV0aFg0QW1NcUZsdV8wam5raWdCQ20ydVNuZHljMEpIUXduRnRldGtqRHBnZ2c4MGRxMU1rMU5Vc1o0Y1d4LWk1Xy1UQ3NXcHFCVUE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYy04N1ZKcGR4NTFZYmg0cDZYbGNnQ0FEbmxnZmQ3MzRBeGZ4R0Q1a2wyaENNakhXZ29hRFpEb2FvVWFLUlZ6QnlIVFNYN2hOaFFsSkZCLWV0aFg0QW1NcUZsdV8wam5raWdCQ20ydVNuZHljMEpIUXduRnRldGtqRHBnZ2c4MGRxMU1rMU5Vc1o0Y1d4LWk1Xy1UQ3NXcHFCVUE?oc=5\" target=\"_blank\">The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2026-02-10T11:24:52+00:00",
      "source": "Finviz"
    },
    {
      "title": "Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of \"Moderate Buy\" by Brokerages - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZFhNellCNlFId05HRDJlbHF1WHgyVVVGRmluYkNURU12dEJpNjhrSUE5UzBSV09ZQVBOS1Zsa1dtdURQQTFmNWEyWm9lSUE2LVRmVldYVEVuZlc3b09TRlNMT0xsbnFZcWJ6UEpNYkJoa1lnNTV0RUxVbmFzZl83bGk5WXllQkV3eGZkZVM2dnZtVjhYS0xUei1QN0drZXhEU1VuVkduMFAtMDZCbVVwUkdoY08xWHlSQS0xQ0RRVHNydmxzd1lONDJKVndWVlM4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZFhNellCNlFId05HRDJlbHF1WHgyVVVGRmluYkNURU12dEJpNjhrSUE5UzBSV09ZQVBOS1Zsa1dtdURQQTFmNWEyWm9lSUE2LVRmVldYVEVuZlc3b09TRlNMT0xsbnFZcWJ6UEpNYkJoa1lnNTV0RUxVbmFzZl83bGk5WXllQkV3eGZkZVM2dnZtVjhYS0xUei1QN0drZXhEU1VuVkduMFAtMDZCbVVwUkdoY08xWHlSQS0xQ0RRVHNydmxzd1lONDJKVndWVlM4?oc=5\" target=\"_blank\">Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of \"Moderate Buy\" by Brokerages</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-10T08:18:49+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNa1A1XzhsX21GQmMxVWNQQWlKSmFsN0d2Zk1saTI4al9sZW1WODJmMFZpMWpRQ1QzbE1qSjZieTU4WEFMblBSeEQxekZjSkZFQm00MmNnVnNhTmlpdmgzYVF3emZBZmptQ2dJVGJnWlh1NFE5TlFreE80SWxjdF8tSUp5enRVenFBMVZrc2lfbnRFLXJDaUV6SzlrcVU1M292TW9kVlFsajBmU0lhdElR?oc=5\" target=\"_blank\">Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-02-03T21:35:04+00:00",
      "source": "Amgen"
    },
    {
      "title": "CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxONHNpNEJGdnZtSjZXNGk4UTFSNmowY1lZUVBnNTduYXlNNFBKZDhWYlYzbm9GaWtIdGJhZnl0S0tpSEdRaTBMMmUySXdEWjBzTUFiQ0xKcEFsWExVTHUtWWhsU2NLVFJ2ei1mVkoxQWRFWGVfNy0wRmpSVWtadkJvWnRSdTZqOE9QOXZMamJYWkN5WG4xZDg0bGlBZGpQMjh5M1VnaXd2VXBOV0MxZERPMjhpbXN3N1c4RkdyVFc5M3hELUtTV0Jhd2ZBUjdEMUhLa2V4blpfdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxONHNpNEJGdnZtSjZXNGk4UTFSNmowY1lZUVBnNTduYXlNNFBKZDhWYlYzbm9GaWtIdGJhZnl0S0tpSEdRaTBMMmUySXdEWjBzTUFiQ0xKcEFsWExVTHUtWWhsU2NLVFJ2ei1mVkoxQWRFWGVfNy0wRmpSVWtadkJvWnRSdTZqOE9QOXZMamJYWkN5WG4xZDg0bGlBZGpQMjh5M1VnaXd2VXBOV0MxZERPMjhpbXN3N1c4RkdyVFc5M3hELUtTV0Jhd2ZBUjdEMUhLa2V4blpfdw?oc=5\" target=\"_blank\">CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-02-05T16:59:56+00:00",
      "source": "Reuters"
    },
    {
      "title": "Amgen, Merck share losses contribute to Dow's 200-point drop - MSN",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNWmpyMVIxNWdBblduakVWQXlUSmVrcG45MXFObXdTR0JfNHUyUUJGckx5dzFvOTZKWm50QWU5ZUppRkJpamFOd1huT0lrc1BDbWNVLVlORXRianBnU3FyNjM4cmRjRlRmYUk3U0UyWUl3MTMwM2pZV3RkekV1TVFrcnlnN0M3WHBwUUxod1N1T1NGcThmMi14SFg5ZExaRUV2TDFKYS1DNUZMaEpqNGw4dg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNWmpyMVIxNWdBblduakVWQXlUSmVrcG45MXFObXdTR0JfNHUyUUJGckx5dzFvOTZKWm50QWU5ZUppRkJpamFOd1huT0lrc1BDbWNVLVlORXRianBnU3FyNjM4cmRjRlRmYUk3U0UyWUl3MTMwM2pZV3RkekV1TVFrcnlnN0M3WHBwUUxod1N1T1NGcThmMi14SFg5ZExaRUV2TDFKYS1DNUZMaEpqNGw4dg?oc=5\" target=\"_blank\">Amgen, Merck share losses contribute to Dow's 200-point drop</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-02-09T15:30:05+00:00",
      "source": "MSN"
    },
    {
      "title": "AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbGlPdTREbHB3UXJRZlFydG9zTGQyMnlkeTcwNmpGaTlQdnhiTDJXN1A5SG9VR2R2VWx1cGVpVmJneU9VVzhwVUo1NFc5REswbXV2S2x5cWxrd2dKV19nOTFmNGlERnhTRXhFMVNmWUhVVll0WEFjR2hSajR4T252LXlSTk9rbFhfMHM1NEJiRVFPVHZReUNQbzNKVWZKbTZOV1haQkZNNFZibHZueVRkMHoxLURNVG04bWZ4dllB?oc=5\" target=\"_blank\">AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-02-03T21:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request - Medical Professionals Reference",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNRS1GUXNRaS1jZzMwS0JhcmJTT3JYc01KdjlwbERzU1pQclhqTVpWZHQ4V091V1VfU2N0N0FSV1RBUFkwM0tqS25JUjY3Ukx3ZG9abGQwYXRtckI2Q215ZzBLZkpuTlliVE1GMHRUM1ZsamxOR0FJVmc3WkZ5cFVlR2pTV0RCRkRRdVdfTG95MTZxemFHX2pWQmZFeWN4TjB5eHVpZg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRS1GUXNRaS1jZzMwS0JhcmJTT3JYc01KdjlwbERzU1pQclhqTVpWZHQ4V091V1VfU2N0N0FSV1RBUFkwM0tqS25JUjY3Ukx3ZG9abGQwYXRtckI2Q215ZzBLZkpuTlliVE1GMHRUM1ZsamxOR0FJVmc3WkZ5cFVlR2pTV0RCRkRRdVdfTG95MTZxemFHX2pWQmZFeWN4TjB5eHVpZg?oc=5\" target=\"_blank\">Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Professionals Reference</font>",
      "published": "2026-02-04T05:00:00+00:00",
      "source": "Medical Professionals Reference"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5\" target=\"_blank\">Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-04T03:18:16+00:00",
      "source": "TipRanks"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-01T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRSg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNLXhOdjVpSkxmUXdQRVpHS2tPVUdGcG1EZHJFZDZpNzg5Y3pCT3FTdlVhNFR4MmhicGVQN0luNnNVMkZCOTF5NkR0WWlUOXVtMmtfbzBJWVE4dUlwbjFXX29sREp3enhLVkowNV9QbXd4UGtMTlJjd29PSHNPSUd3TkhJNm55T1AxRTdUazNkd0NHRThWMGtTZU44V3lidnR5UmQyMWZxd0FrcHVPTVlfWTJWQTFMTGRQRDZQcEtaSlc0TklGNzlMam1pRjhDVVVpc0ZRSg?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-02-09",
      "close": 375.82000732421875
    },
    "history": [
      {
        "date": "2026-01-30",
        "close": 341.8800048828125
      },
      {
        "date": "2026-02-02",
        "close": 344.67999267578125
      },
      {
        "date": "2026-02-03",
        "close": 338.5899963378906
      },
      {
        "date": "2026-02-04",
        "close": 366.20001220703125
      },
      {
        "date": "2026-02-05",
        "close": 367.79998779296875
      },
      {
        "date": "2026-02-06",
        "close": 384.32000732421875
      },
      {
        "date": "2026-02-09",
        "close": 375.82000732421875
      }
    ],
    "name": "Amgen Inc."
  }
}